Sunday, 8 September 2019


08:30 - 12:00

  • CP-01-001-Clinical-grade artificial intelligence: hype or hope for cancer care
  • CP-01-003-Building an AI school for pathology: workflow for Human-AI interfaces
  • LC-01-001-Introduction to ICCR - reporting of nasopharyngeal and oropharyngeal carcinomas
  • LC-01-002-Reporting of oral cavity carcinomas
  • LC-01-003-Reporting of carcinomas of the larynx and hypopharynx
  • LC-01-004-Reporting of salivary gland carcinomas
  • LC-01-005-Reporting of carcinomas of the nose and paranasal sinuses
  • LC-01-006-Reporting of neck dissection specimens
  • OFP-01-001-The influence of the presence of intraductal carcinoma of the prostate on the grade group systems prognostic performance
  • OFP-01-003-A new auto-annotation method and machine learning strategy for detection and annotation of cancer areas in prostate biopsies
  • OFP-01-004-Detection of PD-L1 RNA expression in immunohistochemically negative patients. Are the negatives a heterogenous group?
  • OFP-01-006-Intra and interpatient genetic features of intraductal carcinoma of the prostate
  • OFP-01-007-Papillary Renal Cell Carcinoma with prominent spindle cell stroma - tumour mimicking MESTK , clinicopathologic analysis of 5 cases
  • OFP-01-008-TFEB-amplified renal cell carcinoma: a comprehensive study of 7 novel cases
  • OFP-01-009-Improvement of vascular invasion scoring in stage I testicular non-seminomas to predict relapse during surveillance after orchiectomy
  • OFP-02-001-Risk factors for intraductal tumour spread of submucosal gland in early squamous cell neoplasia: analysis of endoscopically resected specimens
  • OFP-02-002-Site of residual esophageal cancer after neo-adjuvant chemoradiotherapy with regard to the anatomical layers and radiation target volumes at histopathologic examination
  • OFP-02-003-Mechanotransduction in mice colon tumourigenesis : a pathologically reactivated physiological embryonic mechanosensitive pathway
  • OFP-02-004-The prognostic impact of the colorectal cancer microenvironment components and their spatial relationships
  • OFP-02-005-Cell line-derived xenografts: a possible in vivo model to investigate tumour budding in colorectal cancer
  • OFP-02-006-Comprehensive molecular analysis of recurrence in gastrooesophageal adenocarcinoma
  • OFP-02-008-Histopathological and molecular features of adenomatous and serrated colon adenomas, characteristics and overlapping features, challenges in the nomenclature
  • OFP-02-009-Mechanotransduction in mice colon tumourigenesis : a pathologically reactivated physiological embryonic mechanosensitive pathway
  • OFP-02-011-Are tumor budding and tumor grade the same in colorectal cancer?
  • OFP-02-012-Expression of the inhibitory receptor CD94/NKG2A on CD8+ tumour-infiltrating lymphocytes in colorectal cancer: a new promising druggable immune checkpoint in a context of HLA-E/b2microglobuline overexpression by tumour cells
  • OFP-02-013-E-learning for instruction of scoring the tumour-stroma ratio (TSR) in colon carcinoma amongst international pathologists, as part of the UNITED study.
  • OFP-02-014-For better or worse: clinical correlation of SOX9 expression in irradiated rectal cancer
  • SPEC-01-001-Molecular pathology practice in Europe: an overview
  • SPEC-01-002-Molecular pathology practice in Germany
  • SPEC-01-003-Molecular pathology practice in the United Kingdom
  • SPEC-01-005-Molecular pathology practice in Spain
  • SPEC-01-006-Molecular pathology practice in Sweden
  • SPEC-01-007-Molecular pathology practice in France
  • SY-01-001-Invasive or not?
  • SY-01-004-Lobular carcinomas: not a single molecular entity
  • SY-02-002-Lower genital tract squamous neoplasia: classification, markers and recommendations
  • SY-02-004-NHPVA types of endocervical adenocarcinomas
  • SY-02-005-Update on adenosquamous lesions of the cervix: precursors and invasive carcinoma
  • SY-02-006-Update on reporting and issues in staging cervical cancer
  • SY-03-001-Proteomics of FFPE samples
  • SY-03-002-Cancer proteomics
  • SY-03-003-MALDI Imaging in pathology

12:15 - 13:00

  • KL-01-001-Imaging and pathology

14:45 - 16:45

  • CP-02-001-Embracing digital and computational pathology: a calling for pathologists as leaders in precision medicine
  • CP-02-002-Embedding AI into digital pathology workflows
  • CP-02-003-Enhancing digital pathology with artificial intelligence
  • SC-01-002-Inflammatory breast cancer: the pathologists' perspective
  • SC-01-004-ASCO/CAP HER2 guidelines update
  • SC-02-003-Update on squamous intra-epithelial lesions of the larynx
  • SC-02-005-IgG4 related diseases of the head and neck
  • SS-01-001-Case 1
  • SS-01-003-Case 3
  • SS-01-004-Case 4
  • SS-01-005-Case 5
  • SS-01-006-Case 6
  • SY-04-003-Microsatellite instability testing: which analysis in routine practice for the pathologist?
  • SY-04-004-The next generation of microsatellite instability testing
  • SY-04-005-Immunotherapy in metastatic colo-rectal cancer (mCRC): the potential of immune checkpoint inhibitors
  • SY-05-001-Fusobacterium and colorectal cancer: fact or myth
  • SY-05-004-Panel Discussion: Cancer & microbiome - will the new knowledge impact future diagnostic pathology
  • SY-06-005-Complement mediated glomerulopathies
  • VA-01-002-What is new in epithelioid soft tissue tumours?
  • VA-01-003-What is new in adipocytic neoplasia?
  • VA-01-006-What is new in the immunohistochemical and molecular genetic study of selected aspects of soft tissue tumours?

17:15 - 19:15

  • CP-03-000-Intro
  • CP-03-001-Deep learning enables fully automated mitotic density assessment in breast cancer histopathology
  • CP-03-002-Automated grading of urothelial cell carcinoma of the bladder
  • CP-03-003-Unsupervised anomaly detection: application to colorectal liver metastasis
  • CP-03-004-Automated Ki67 hot-spot detection and analysis leads to higher Ki67 proliferation indices
  • CP-03-005-U-Net ensembles for accurate classification of oesophageal adenocarcinoma
  • CP-03-006-Artificial intelligence driving automated pathology: iCAIRD and beyond
  • OFP-03-001-Negative ThyroSeq® genomic testing for indeterminate thyroid nodules: the memorial sloan kettering cancer center experience
  • OFP-03-002-Ultrasound guided fine needle aspiration of thyroid: inadequacy rate with rapid on site evaluation
  • OFP-03-004-The value of fine needle aspiration cytology in the examination of parathyroid lesions; role of immunocytochemistry and washout fluid analysis
  • OFP-03-006-BRAF mutation prediction from metastatic melanoma cytological smear using deep learning: an ongoing project
  • OFP-03-007-Metabonomics profiling of malignant peritoneal effusion with 1H-NMR spectroscopy
  • OFP-03-009-Correlation between the ultrasound-guided thyroid fine-needle aspiration cytology with molecular testing and surgical histopathology results
  • OFP-03-011-Contribution of TERT promoter mutation status to preoperative diagnosis of thyroid carcinoma
  • OFP-03-012-Thyroid nodules with AUS/FLUS cytology: what happens next?
  • SC-03-001-Small cell carcinoma of the ovary of hypercalcaemic type: unravelling the mysteries of a tumour unique to the ovary
  • SC-03-002-Differential diagnosis of ovarian mucinous tumours
  • SC-03-003-Ovarian Sertoli-Leydig cell tumours
  • SC-03-004-Histologic heterogeneity of seminoma of the testes
  • SC-03-005-Non seminomatous germ cell tumours of the testes. An update
  • SS-02-001-Case 1
  • SS-02-002-Case 2
  • SS-02-003-Case 3
  • SS-02-004-Case 4
  • SS-02-006-Case 6
  • SS-03-003-Case 3
  • SS-03-005-Case 5
  • SS-03-006-Case 6
  • SS-03-007-Case 7
  • SY-07-001-New developments of in situ methods
  • SY-07-004-Immunohistochemistry in clinical research
  • SY-09-001-Pathology in the Horn of Africa: the APOF project in Somaliland
  • SY-09-002-Prevention and diagnosis of breast cancer in a conflict area: the experience in Herat, Afghanistan
  • SY-09-003-Pathology services in a low resource setting: University of Abuja Teaching Hospital, Abuja, Nigeria experience
  • SY-09-005-The many roads to diagnosis of tuberculosis: experience of a tertiary care centre in southwest coastal India
  • SY-09-006-Cytology as a tool in diagnosis of toxoplasma